← Leaderboards
Lawrence B Schook
University Of Illinois Urbana-Champaign
$1,366,026
Attributed
$3,033,077
Total exposure
4
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1M · FY2010–24$2M$1.5M$1M$500K$0
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$3,033,077 · 4
By mechanism
R44$2,000,000 · 1
R01$1,000,577 · 1
R13$32,500 · 2
Top collaborators
- Geoffrey J. Clark4 shared
- Lauretta Rund4 shared
- Kyle Schachtschneider2 shared
Others in their field
Top investigators on “Family Suidae”
- David H Sachs · Columbia University Health Sciences$27,938,778
- David A Stoltz · University Of Iowa$23,917,771
- Jianyi Zhang · University Of Alabama At Birmingham$20,789,788
- Dafna Bar-Sagi · State University New York Stony Brook$19,477,294
- Devendra K. Agrawal · Creighton University$19,059,808
- Joseph Zabner · University Of Iowa$19,038,827
Research focus
Family SuidaeAnimalsGeneticMalignant NeoplasmsCancer ModelTumorigenicMutationIn VivoInterestMonitorImageTechnologyTranslationsTumorCancer TherapyCellsAnimal ModelTransgenic OrganismsBiomedical ResearchHuman DiseaseBiological ModelsSeriesBiological FactorsCoupled
Grant awards (8)
Validation of the Genetically Malleable Oncopig Hepatocellular carcinoma (HCC) Model for Targeted Therapeutic Development$1,035,724
R44 · FY2024 · CA
Validation of the Genetically Malleable Oncopig Hepatocellular carcinoma (HCC) Model for Targeted Therapeutic Development$964,276
R44 · FY2023 · CA
Oncopigs as a better model for human cancer$292,476
R01 · FY2013 · CA
Oncopigs as a better model for human cancer$309,806
R01 · FY2012 · CA
Oncopigs as a better model for human cancer$196,106
R01 · FY2011 · CA
Swine in Biomedical Research Conference 2011 Creating the Building Blocks: Genomi$10,000
R13 · FY2011 · RR · contact PI
Oncopigs as a better model for human cancer$202,189
R01 · FY2010 · CA
Swine in Biomedical Research conference$22,500
R13 · FY2004 · RR